Rare diseases
Investigational molecules
Locations
Back to Hungary346 clinical trials in Pecs, Hungary across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
A Study of Brivekimig Compared to Placebo in Patients with Moderate to Severe Hidradenitis Suppurativa
HungaryA study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis
HungaryA Study of Amivantamab With Carboplatin and Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
HungaryA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
HungaryA Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress
HungaryA Study of fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.
HungaryA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
HungaryStudy of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy
HungaryStudy of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
HungaryStudy of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness
HungaryStudy of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment
HungaryStudy of GHZ339 for treatment of moderate to severe atopic dermatitis
HungaryThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for chronic rhinosinusitis and asthma, with studies evaluating new therapeutic approaches for both conditions with and without nasal polyps.
Multiple trials investigating novel medications to improve respiratory symptoms and patient quality of life.
Groundbreaking studies in heart failure prevention and cardiomyopathy, exploring new therapeutic options for various cardiovascular conditions.
Advanced research aimed at reducing cardiovascular events and improving patient outcomes.
Innovative research into treatments for systemic sclerosis and Sjögren's syndrome, focusing on novel therapeutic approaches for these challenging conditions.
Studies evaluating new biological treatments to address various autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
